Biofil Chemicals & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Biofil Chem & Pharma	Vivimed Labs	JFL Life Sciences
Operational Metrics
Financials
5 yr Average ROE	4.39 %	184.61 %	12.26 %
5yr average Equity Multiplier	2.06	-33.72	2.68
5yr Average Asset Turnover Ratio	0.95	0.27	0.93
5yr Avg Net Profit Margin	2.38 %	-54.08 %	5.75 %
Price to Book	2.11	0.0	1.4
P/E	16.3	0.0	12.25
5yr Avg Cash Conversion Cycle	75.63 Days	184.52 Days	138.58 Days
Inventory Days	28.27 Days	244.76 Days	96.42 Days
Days Receivable	389.8 Days	246.32 Days	135.23 Days
Days Payable	203.89 Days	159.64 Days	103.44 Days
5yr Average Interest Coverage Ratio	23.53	-6.61	4.03
5yr Avg ROCE	6.37 %	-13.87 %	17.72 %
5yr Avg Operating Profit Margin	3.78 %	-26.56 %	10.31 %
5 yr average Debt to Equity	0.03	-13.68	0.9
5yr CAGR Net Profit	-14.7 %	-14.97 %	50.43 %
5yr Average Return on Assets	2.37 %	-10.44 %	5.01 %
Shareholdings
Promoter Holding	46.79 %	7.77 %	67.47 %
Share Pledged by Promoters	0.0	14.8 %	0.0
Change in Promoter Holding (3 Yrs)	-0.03 %	-13.19 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Biofil Chem & Pharma	Vivimed Labs	JFL Life Sciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Chemicals Div 0 Pharma 0 Speciality Chemicals 0 Pharmaceutical Products 0	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceutical Products 0 Speciality Chemicals 0 Pharmaceuticals 0 Chemicals Div 0	Product Wise Break-Up Pharma 0 Pharmaceuticals 100.0 Speciality Chemicals 0 Pharmaceuticals 0 Chemicals Div 0
Operating Profit Break-Up	Operating Profit Break-Up Chemicals 100.0 Pharma Div 0 Pharma 0 Specialty Chemicals 0	Operating Profit Break-Up Pharma Div 0 Chemicals 0 Specialty Chemicals 100.0 Pharma 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise Pharma 69.52 Chemical 30.48	-	-